San Diego-based Genalyte Inc. won a Small Business Innovation Research (SBIR) grant to develop multiplexed diagnostic assays for the early detection and monitoring of type 1 diabetes. 
A study led by researchers from the University of California, San Diego School of Medicine has found a correlation between vitamin D3 serum levels and subsequent incidence of Type 1 diabetes.
During American Diabetes Month, Palomar Health diabetes experts are drawing attention to some shocking statistics about the disease and providing information to people who are concerned about diabetes-related amputations.
The number of people living with diabetes is soaring in the United States, as 18 states had at least a doubling in those with the illness since 1995, a government survey found.
Stephen S. was shocked when he heard the news: He had type 2 diabetes.
During American Diabetes Month this November, the American Diabetes Association will launch a socially-focused initiative, "A Day in the Life of Diabetes," to demonstrate the increasing impact diabetes has on families and communities nationwide.
The heart risks with Novo Nordisk A/S’s once-a-day insulin Tresiba are probably not of enough concern to block approval of the medicine, the majority of an advisory panel to the U.S. Food and Drug Administration said.
COPENHAGEN, Denmark (AP) -- Danish pharmaceutical company Novo Nordisk A/S (NYSE: NVO) says its net profit grew by 35 percent in the third quarter of 2012, chiefly spurred by strong sales of its diabetes drugs.
INDIANAPOLIS (AP) -- Drugmaker Eli Lilly says it is planning a multi-million dollar expansion of its manufacturing operations to make cartridges that deliver insulin to patients.
In a new study published in "Aging Cell," researchers at the Salk Institute for Biological Studies show, for the first time, that diabetes enhances the development of aging features that may underlie early pathological events in Alzheimer's.
ViaCyte Inc. scored a $10.1 million award from the California Institute for Regenerative Medicine (CIRM) to continue working on a transformative cell therapy that has the potential to essentially cure patients with type 1 diabetes.
San Diego-based West Health Investment Fund, focused on lowering health care costs, has announced it participated in the recent venture financings of GlySens Inc. and RxAnte Inc., two startup companies with technologies aimed at lowering the cost of health care.
Press ESC | Close [X]
